Future of Medical Radioisotope Supply Discussed at NEA Workshop
The Nuclear Energy Agency (NEA) recently convened a workshop to explore advancements and challenges in the supply of medical radioisotopes.
Editorial Staff Apr 23
University of Toronto Researchers Uncover Sustainable Path for Cosmetics Production
A recent discovery by researchers at the University of Toronto reveals that certain bacteria can transform waste into valuable chemicals, potentially transforming the cosmetics industry.
Editorial Staff Apr 22
Kennedy Shifts Toward a Moderate Stance on MAHA
In a notable shift, Kennedy is adjusting his approach to MAHA, stepping back from several key issues while still making an impact in health care.
Editorial Staff Apr 22
Concerns Emerge as Former Tobacco Executive Takes Senior Role at CDC
The appointment of a former Imperial Brands executive to a senior position at the CDC has sparked concerns about potential tobacco industry influence within the agency.
Editorial Staff Apr 22
Robert F. Kennedy Jr. Appears Before Senate HELP Committee
Robert F. Kennedy Jr. is set to testify before the Senate's health care panel today. Viewers can watch the proceedings live as he addresses the committee.
Editorial Staff Apr 22
Biotech Update: RevMed, Roche, and Kyverna CAR-T Therapy Insights
Stay informed with the latest developments in the biotech sector, featuring updates on RevMed, Roche, and Kyverna's CAR-T therapy.
Editorial Staff Apr 22
Understanding Vibrio: Risks Associated with Coastal Waters and Shellfish
As summer approaches, it's essential to be aware of Vibrio, a bacteria present in coastal waters and raw shellfish, to ensure safe beach outings and seafood consumption.
Editorial Staff Apr 22
The MAHA Snack Revolution: Healthier Choices or Just Hype?
The rise of MAHA snacks, from protein-infused Pop-Tarts to avocado-oil chips, suggests a shift towards healthier eating. However, nutrition experts caution that the benefits may be overstated.
Editorial Staff Apr 22
Exploring the Complex Narratives Behind Pharmaceutical Innovations
Thomas Goetz emphasizes that each drug represents a broader narrative involving health, medicine, society, and economics.
Editorial Staff Apr 22
Celebrating 75 Years of the CDC’s EIS Program: A Legacy of Public Health Leadership
The CDC’s Epidemic Intelligence Service has reached a significant milestone, having trained over 4,300 individuals who are now integral to public health efforts.
Editorial Staff Apr 22
Roche Pursues Regulatory Approval for MS Drug Despite Ongoing Safety Concerns
Roche is advancing its experimental multiple sclerosis drug to regulators following successful trials, though significant safety concerns persist.
Editorial Staff Apr 21
Mapping the Rose Pangenome: A Step Forward in Breeding Innovation
A recent study has mapped 55,000 genes in roses, which are vital ornamental plants. This research could significantly influence breeding practices, as currently, less than 10% of rose species are utilized.
Editorial Staff Apr 21
GOP Senators Stand Firm Against Proposed Cuts to NIH and HHS Reorganization
In a notable move, key Republican senators are likely to oppose President Trump's proposed cuts to the National Institutes of Health and the reorganization of Health and Human Services for the second consecutive year.
Editorial Staff Apr 21
Analyzing the U.S. Contribution to Global Health Initiatives
As the leading donor in global health, the U.S. government allocates its budget across several critical program areas, including HIV, tuberculosis, and malaria.
Editorial Staff Apr 21
Purdue Pharma's $225 Million Forfeiture Paves the Way for Settlement Finalization
A judge is anticipated to impose a $225 million forfeiture on Purdue Pharma, the maker of OxyContin, facilitating the completion of its settlement with the Justice Department.
Editorial Staff Apr 21
Purdue Pharma to Forfeit $225 Million in Settlement with Justice Department
A U.S. judge is anticipated to order Purdue Pharma to forfeit $225 million, marking a significant step in ongoing legal proceedings.
Editorial Staff Apr 21
Changes to CDC Conference Accessibility Raise Concerns
Recent developments indicate that a CDC conference, previously open to the public, may now have restricted access. This follows a federal ruling related to gender declaration and highlights ongoing issues in health policy.
Editorial Staff Apr 21
KFF Launches New Podcast to Navigate Health Policy and Business
KFF is set to debut a podcast hosted by Chip Kahn, focusing on the intricate relationship between health policy and business. The initiative aims to deepen understanding of these complexities.
Editorial Staff Apr 21
Rethinking the U.S. Health Care System: A Look Backward
The current U.S. health care system appears to prioritize retrospective evaluations, questioning the justification of past medical decisions.
Editorial Staff Apr 21
Examining the Impact of Trump's Executive Actions on LGBTQ+ Health
This analysis explores the Executive Actions from the Trump administration that may affect the health of LGBTQ+ individuals, detailing their potential implications.
Editorial Staff Apr 21